Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern therapeutics. Biostar's core offerings include a range of prescription and over-the-counter medications, with a focus on unique formulations that blend traditional practices with contemporary science. The company has achieved significant milestones, including successful product launches and strategic partnerships, which have bolstered its market position. Renowned for its commitment to quality and efficacy, Biostar Pharmaceuticals continues to make strides in enhancing healthcare solutions, solidifying its reputation within the global biopharmaceutical landscape.
DitchCarbon Score
How does Biostar Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biostar Pharmaceuticals, Inc.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biostar Pharmaceuticals, Inc.'s reported carbon emissions
Biostar Pharmaceuticals, Inc., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or climate pledges available, it is unclear how Biostar Pharmaceuticals is addressing its carbon footprint or contributing to broader industry climate goals. The lack of reported emissions and commitments suggests that the company may need to enhance its transparency and engagement in climate action to align with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biostar Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
